Sensus Healthcare Inc. (SRTS) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Sensus Healthcare Inc. (SRTS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

6.61

0.23 (3.61%)

At close: Jan 14, 2025, 3:59 PM

6.61

0.00%

After-hours Jan 14, 2025, 06:44 PM EST

undefined% (undefined)

Bid	6.43
Market Cap	108.34M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.57
PE Ratio (ttm)	11.6
Forward PE	n/a
Analyst	Strong Buy

Ask	6.87
Volume	248,859
Avg. Volume (20D)	211,685
Open	6.40
Previous Close	6.38
Day's Range	6.40 - 6.87
52-Week Range	2.61 - 9.33
Beta	undefined

About SRTS

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and s...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jul 26, 2016

Employees 35

Stock Exchange NASDAQ

Ticker Symbol SRTS

Website https://www.sensushealthcare.com

Analyst Forecast

According to 2 analyst ratings, the average rating for SRTS stock is "Strong Buy." The 12-month stock price forecast is $12.5, which is an increase of 89.11% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Sensus Healthcare Inc. is scheduled to release its earnings on Feb 6, 2025, during market hours.
Analysts project revenue of $10.31M, reflecting a -17.95% YoY shrinking and earnings per share of 0.11, making a -57.69% decrease YoY.

Why Price Moved

1 month ago · Source

+10.08%

Sensus Healthcare shares are trading higher after ... Unlock content with Pro Subscription

8 months ago · Source

+38.85%

Sensus Healthcare shares are trading higher after following the company's better-than-expected Q1 financial results.

News

1 week ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade

The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $6.83, representing a -1.87% change from its previous close.

2 weeks ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Sees a More Significant Dip Than Broader Market: Some Facts to Know

The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $7.21, representing a -1.77% change from its previous close.

2 weeks ago · zacks.com

Sensus Healthcare (SRTS) Surges 7.9%: Is This an Indication of Further Gains?

Sensus Healthcare (SRTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

1 month ago · zacks.com

Wall Street Bulls Look Optimistic About Sensus Healthcare (SRTS): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

1 month ago · zacks.com

Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 36.01%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 36% in Sensus Healthcare (SRTS). While the effectiveness of this highly sought-after metric is questionable, th...

1 month ago · zacks.com

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Here is how Sensus Healthcare, Inc. (SRTS) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.

1 month ago · zacks.com

Wall Street Analysts See a 39.66% Upside in Sensus Healthcare (SRTS): Can the Stock Really Move This High?

The mean of analysts' price targets for Sensus Healthcare (SRTS) points to a 39.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon...

1 month ago · zacks.com

What Makes Sensus Healthcare (SRTS) a Good Fit for 'Trend Investing'

Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro...

2 months ago · seekingalpha.com

Sensus Healthcare: Q3 Results Showed That The Stock Is Undervalued

Sensus Healthcare's Q3 results exceeded expectations with 127% YoY revenue growth and EPS of $0.07, showcasing strong demand recovery and effective management strategies. The Fair Deal Agreement and n...

2 months ago · seekingalpha.com

Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript

2 months ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.09 per share a year a...

2 months ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know

Sensus Healthcare, Inc. (SRTS) reachead $6.44 at the closing of the latest trading day, reflecting a +1.58% change compared to its last close.